• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

DG051 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5764305

MBS5764305 is an inhibitor targeting DG051. DG051 is a potent leukotriene A4 hydrolase (LTA4H) inhibitor (IC50: 47nM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
DG051, Inhibitor
Full Product Name
DG051
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
426.33
Solubility
DMSO: 317mg/mL (743.56mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C21H24Cl2NO4
SMILES
Cl.Cc1ccc(Oc2ccc(OC[C@@H]3CCCN3CCCC(O)=O)cc2)cc1
CAS Number
929915-58-2
In Vitro
DG051 is a potent inhibitor of LTA4H aminopeptidase activity against L-alanine p-nitroanilide (IC50: 72nM). DG051 inhibits human whole blood (HWB) with IC50 of 37nM [1]. DG-051 is an LTA4H inhibitor, currently in Phase II clinical development for the prevention of heart attack [2].

Product Categories/Family for DG051, inhibitor

Structure of DG051, inhibitor

DG051 Inhibitor – Cat# MBS5764305

Product References and Citations for DG051, inhibitor

Sandanayaka V, et al. Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis. J Med Chem. 2010 Jan 28;53(2):573-85.
Sandanayaka V, et al. Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis. J Med Chem. 2010 Jan 28;53(2):573-85.
Enache LA, et al. Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6275-9.
Enache LA, et al. Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6275-9.

Other Notes

Small volumes of DG051, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000